Abstract
ObjectiveBone marrow mesenchymal stem cells-derived exosomes (BMSCs-exo) carrying microRNA (miR) cargo have been emerged as a promising therapy for human cancers. Therein, we pivoted on the integral function of BMSCs-exo and miR-205–5p in liver cancer through mediation of cyclin-dependent kinase-like 3 (CDKL3). MethodsPatients with liver cancer were enrolled to collect the clinical tissue and determine miR-205–5p and CDKL3 expression. miR-205–5p expression in BMSCs was altered by transfection, and BMSCs-exo were extracted and co-cultured with LM3 cells. Meanwhile, LM3 cells were independently transfected with CDKL3 low or high expression vector. Since then, cell growth in vitro was observed, and the effect of exosomal miR-205–5p on tumor growth in vivo was further investigated. ResultsmiR-205–5p expression was low while CDKL3 was high in liver cancer. BMSCs-exo blocked cellular growth of liver cancer in vitro and in vivo. Overexpressing exosomal miR-205–5p decelerated the biological development of liver cancer cells while suppressing exosomal miR-205–5p had the contrary function in vitro and in vivo. Loss of CDKL3 impaired the malignant activities of liver cancer cells, and could even impair the pro-tumor effects of down-regulated exosomal miR-205–5p. ConclusionIt is clearly concluded that BMSCs-secreted exosomal miR-205–5p exerts inhibitory effect on the progression of liver cancer through regulating CDKL3.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.